Literature DB >> 32120251

What drives antibiotic use in the community? A systematic review of determinants in the human outpatient sector.

Dennis Schmiege1, Mariele Evers2, Thomas Kistemann3, Timo Falkenberg4.   

Abstract

Inadequate and excessive use of antibiotics in humans, animals, and plants has been identified among the key drivers of antibiotic resistance (ABR). In human medicine, the great majority of antibiotics are prescribed in the outpatient sector with profound differences in antibiotic consumption across various geographical scales and between health care sectors; raising questions around the underlying drivers. Moving beyond individual patient-related determinants, determinants of antibiotic use in the outpatient sector were categorized as compositional, contextual and collective, enabling an analysis of potential area effects on antibiotic use. 592 variables identified in 73 studies were sorted into 46 determinant groups. Compositional determinants provided the strongest evidence with age, education, employment, income, and morbidity exhibiting a clear influence on antibiotic use. Regarding contextual and collective determinants, deprivation, variables around health care services, Hofstede's dimensions of national culture and regulation affect antibiotic use. The results are biased towards high-income and western countries, often relying on secondary data. However, the findings can be used as signposts for associations of certain variables with antibiotic use, thereby enabling further research and guiding interventions.
Copyright © 2020 The Authors. Published by Elsevier GmbH.. All rights reserved.

Entities:  

Keywords:  Antibiotic use; Antimicrobial resistance; Area effects; Community; Determinants; Outpatient sector

Mesh:

Substances:

Year:  2020        PMID: 32120251     DOI: 10.1016/j.ijheh.2020.113497

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  6 in total

1.  Factors influencing antimicrobial resistance in the European food system and potential leverage points for intervention: A participatory, One Health study.

Authors:  Irene Anna Lambraki; Melanie Cousins; Tiscar Graells; Anaïs Léger; Patrik Henriksson; Stephan Harbarth; Max Troell; Didier Wernli; Peter Søgaard Jørgensen; Andrew P Desbois; Carolee A Carson; Elizabeth Jane Parmley; Shannon Elizabeth Majowicz
Journal:  PLoS One       Date:  2022-02-22       Impact factor: 3.240

2.  Prevalence and predictors of self-medication with antibiotics in selected urban and rural districts of the Dodoma region, Central Tanzania: a cross-sectional study.

Authors:  Richard James Mabilika; Emmanuel Mpolya; Gabriel Shirima
Journal:  Antimicrob Resist Infect Control       Date:  2022-06-16       Impact factor: 6.454

3.  Transmission of gram-negative antibiotic-resistant bacteria following differing exposure to antibiotic-resistance reservoirs in a rural community: a modelling study for bloodstream infections.

Authors:  Eduardo A Undurraga; Jasmina Panovska-Griffiths; Kasim Allel; Lara Goscé; Rafael Araos; Daniel Toro; Catterina Ferreccio; Jose M Munita
Journal:  Sci Rep       Date:  2022-08-05       Impact factor: 4.996

Review 4.  Prevention and Control of Multidrug-Resistant Bacteria in The Netherlands and Germany-The Impact of Healthcare Structures.

Authors:  Robin Köck; Karsten Becker; Evgeny A Idelevich; Annette Jurke; Corinna Glasner; Ron Hendrix; Alexander W Friedrich
Journal:  Int J Environ Res Public Health       Date:  2020-03-30       Impact factor: 3.390

Review 5.  Exploring gender differences in knowledge and practices related to antibiotic use in Southeast Asia: A scoping review.

Authors:  Phuc Pham-Duc; Kavitha Sriparamananthan
Journal:  PLoS One       Date:  2021-10-26       Impact factor: 3.240

6.  Associations between socio-spatially different urban areas and knowledge, attitudes, practices and antibiotic use: A cross-sectional study in the Ruhr Metropolis, Germany.

Authors:  Dennis Schmiege; Timo Falkenberg; Susanne Moebus; Thomas Kistemann; Mariele Evers
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.